CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
24.18
-0.98 (-3.90%)
May 13, 2025, 4:00 PM - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
Bladder-sparing Therapeutic
204.00K
Log In
Log In
Bladder-sparing Therapeutic Growth
6.81%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021
Period Ending
Dec '23 Dec '22 Dec '21
United States
204.00K
Log In
Log In
United States Growth
6.81%
Log In
Log In